Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Other financing activities (2017)

Historic Other financing activities for Amicus Therapeutics (FOLD) over the last 4 years, with Q4 2017 value amounting to $23.1 million.

  • Amicus Therapeutics' Other financing activities changed N/A to $23.1 million in Q4 2017 from the same period last year, while for Sep 2018 it was $23.1 million, marking a year-over-year increase of 1661956.52%. This contributed to the annual value of $23.1 million for FY2017, which is 3197.55% up from last year.
  • As of Q4 2017, Amicus Therapeutics' Other financing activities stood at $23.1 million.
  • In the past 5 years, Amicus Therapeutics' Other financing activities ranged from a high of $23.1 million in Q4 2017 and a low of $28000.0 during Q1 2017
  • For the 3-year period, Amicus Therapeutics' Other financing activities averaged around $5.8 million, with its median value being $110000.0 (2013).